Revon Media
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
Revon Media
No Result
View All Result

Reszon to make Chembio’s HIV test kits

Reszon to make Chembio’s HIV test kits

From left: CDM Director Avijit Roy, Chembio Executive Vice President and Chief Science & Technology Officer Javan Esfandiari and Reszon CEO EL Law.

Share on FacebookShare on Twitter

Partnership will see combining resources and manufacturing strengths in the diagnostics space

BY KHIRTINI K KUMARAN

CHEMBIO Diagnostics, Inc (Chembio) has signed a manufacturing agreement with Reszon Diagnostics International Sdn Bhd (Reszon) to produce Chembio’s HIV 1/2 STAT-PAK Assay products in Malaysia.

In an announcement on May 17, 2022, Chembio said the kits would be manufactured at Chembio Diagnostics Malaysia Sdn Bhd’s (CDM) facility, which had previously suspended operations in May 2020.

This new manufacturing arrangement will leverage CDM’s product and facility qualification by the World Health Organisation Prequalification Program and ISO 13485 certification. Chembio’s manufacturing abilities will be combined with Reszon’s resources and manufacturing strengths in the diagnostics space in this partnership.

Operations are expected to commence in the third quarter of 2022, dependent on reaching certain quality, production, and other targets.

Chembio’s CEO and President Richard Eberly said: “We are excited to be working with Reszon, a leader in Malaysian diagnostics test kits, to optimise our global manufacturing by leveraging our Malaysian resources. It represents a significant milestone in our Global Competitiveness Program to improve profitability.

“We believe this new relationship will increase our capacity to supply new markets, bolster our competitiveness and strengthen our position in rapid point-of-care testing.

“We look forward to exploring commercial opportunities in Malaysia and other high-growth markets.”

Chembio is a leading diagnostics company focused on developing and commercialising point-of-care tests to detect and diagnose infectious diseases, including sexually transmitted infections, insect vector and tropical disease, Covid-19 and other viral and bacterial infections, enabling expedited treatment.

Leveraging each other’s strengths

With Chembio’s extensive scientific expertise, its novel DPP technology offers broad market applications beyond infectious disease.

Reszon’s CEO EL Law said: “Chembio offers best-in-class technology, and we are confident we can significantly scale manufacturing of their tests. We are eager to work with the entire Chembio team and will expand our business in the Malaysian and international markets.

“We see this as an excellent opportunity for both parties to leverage our strengths. We feel this can take us both to the next level of commercial success and look forward to a long and mutually beneficial relationship.”

Reszon, established in 2010, develops and manufactures a strong portfolio of innovative in-vitro diagnostics (IVD) rapid tests and ELISA kits for medical professionals, including clinical diagnostic markets worldwide.

It is the largest regional supplier of Covid-19 self-test kits, having supplied over 20 million kits in Southeast Asia. It is working to fully automate its manufacturing process to remain competitive in the worldwide market and provide the most cost-effective self-testing diagnostics. — The Health

Tags: Chembio Diagnostics IncDiagnosticsInnovationReszon Diagnostics InternationalThe Health 2022The Health May/June 2022theHealth
Previous Post

Know your brain

Next Post

Proper food handling

Live Edition Paper

NOV 2020 ePaper

OCT 2020 ePaper


 

Subscribe for free complimentary live editions:

Recent News

  • SEERS expands its health hubs
    December 22, 2022
    SEERS Bhd, a listed company anchored in producing innovative technology in the […]
  • Spritzer works closely with frontliners
    October 6, 2021
    Spritzer Malaysia (Spritzer), which produces Malaysia’s best-selling natural […]
  • Boom times for pharma M&A
    March 1, 2021
    Global mergers and acquisitions (M&A) activity last year was expected to […]
  • At what age can my child start wearing contact lenses?
    October 14, 2021
    It is important that parents and children get proper guidelines from their […]
  • Protect your eyes from harmful UV
    October 6, 2021
    Just like using sunscreen for our skin, our eyes need protection too as damage […]

Connect

Office

Revon Media Sdn Bhd
A member of Revongen Corporation
Headquarters
Revongen Corporation Center,
Level 17, Top Glove Tower, No.16,
Persiaran Setia Dagang,Setia Alam,
Seksyen U13, 40170 Shah Alam,
Selangor Darul Ehsan, Malaysia.

Contact

Tel: +603 3359 1166
Fax: +6 03 3358 0303

Copyright © 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd. About Us | Contact Us | Privacy Policy | Terms of use

No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us

© 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist